MongoDB (MDB): Evaluating Valuation as Earnings Loom and New AI Initiatives Shape Market Sentiment

If you are watching MongoDB (MDB) right now, you are definitely not alone. With the company set to report earnings on August 26, all eyes are on how its revenue growth stacks up against the forecasted dip in earnings per share. At the same time, MongoDB is rolling out new AI embedding models and growing its partner ecosystem. These moves could reshape how developers and businesses build AI-powered applications. Investors are weighing whether these efforts will act as meaningful catalysts or if they represent longer-term initiatives that may take time to impact the bottom line. It has been a mixed ride for MongoDB’s stock over the past year. Despite a surge in Atlas revenue growth and customer additions, shares have slipped 11% in the last twelve months. The recent quarter saw the stock underperform both the major indexes and sector peers. Some observers attribute this to shifting market perceptions around risk and future profit growth. Even with strong top-line expansion, the market appears to be waiting for MongoDB to convert that growth into sustainable profit. With the stock drifting lower while revenue continues to climb, investors are considering whether MongoDB is trading at a discount or if the market has already incorporated expectations for future growth.
Advertisement

Most Popular Narrative: 19.5% Undervalued

According to community narrative, MongoDB is considered nearly 20% undervalued based on strong growth expectations and bold strategic bets in AI and app modernization.

With the rise of AI, MongoDB foresees gradual but incremental contributions to revenue growth as enterprises develop competencies in leveraging AI, impacting both revenue and future net margins.

Want to know the foundation for this bullish outlook? The narrative hints at aggressive growth rates, major market shifts, and a dramatic improvement in profitability by the end of the decade. Which assumptions back up this premium price? Brace yourself, as the drivers behind this valuation could surprise you.

Result: Fair Value of $272.26 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the anticipated benefits from AI may take time to materialize, and volatility in Atlas consumption could pose challenges to MongoDB’s future revenue growth.

Find out about the key risks to this MongoDB narrative.

Another View: What Do Cash Flows Say?

Looking at our DCF model, the story shifts. While the earlier approach relied on assumptions for future growth, the DCF compares the present and future cash flows directly. Does this method support the optimism, or is more caution needed?

Look into how the SWS DCF model arrives at its fair value.

MDB Discounted Cash Flow as at Aug 2025
MDB Discounted Cash Flow as at Aug 2025

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out MongoDB for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own MongoDB Narrative

If our view doesn’t match your perspective, you’re invited to dive into the numbers and assemble your own outlook in just a few minutes. do it your way.

A great starting point for your MongoDB research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.

Looking for More Winning Investment Ideas?

Don’t stop with MongoDB when so many other exciting opportunities are within reach. The right investment could be just a click away, and the Simply Wall Street Screener gives you smart, targeted ways to find them. Don’t let the market move without you. Set yourself up for success with strategies built for today’s world.

  • Capture long-term income streams by targeting companies offering dividend stocks with yields > 3%. This approach gives you the potential for steady returns even in uncertain markets.
  • Power up your portfolio with transformative innovation by seeking out leaders in AI penny stocks. Here, artificial intelligence is opening up entirely new frontiers in growth.
  • Stay ahead of the crowd by going after undervalued stocks based on cash flows. This helps you spot quality businesses that may be trading below their true worth before others catch on.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGM:MDB

MongoDB

Provides general purpose database platform worldwide.

Flawless balance sheet with reasonable growth potential.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1156.7% undervalued
52 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative
BL
BlackGoat
IREN logo
BlackGoat on IREN ·

IREN's Bold Moves in Sustainable Bitcoin Mining & AI Data Centers

Fair Value:US$71.4852.5% undervalued
205 users have followed this narrative
6 users have commented on this narrative
32 users have liked this narrative
HE
HedgeY
ARM logo
HedgeY on Arm Holdings ·

The Architecture Layer of AI Computing - But Priced Like the Future Already Arrived?

Fair Value:US$43043.1% undervalued
9 users have followed this narrative
1 users have commented on this narrative
3 users have liked this narrative
HI
Hidden_Rock_Capital
FISV logo
Hidden_Rock_Capital on Fiserv ·

Temporary "perfect storm" leads to opportunity to buy financial services leader for less than 5x long-term earnings

Fair Value:US$119.9954.8% undervalued
13 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative

Updated Narratives

ON
LOT logo
Ontological on Lotus Technology ·

Lotus Tech, Finloop and FOMO Pay Collaborate to Explore Vehicle Tokenization

Fair Value:US$2.463.7% undervalued
1 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
NE
AIIO logo
newsfinder11221 on Robo.ai ·

Robo.ai (NASDAQ: AIIO): Building the Infrastructure Behind the AI Revolution

Fair Value:US$539.0% undervalued
1 users have followed this narrative
3 users have commented on this narrative
0 users have liked this narrative
EU
European_Hidden_Gem_Stocks
ALMIN logo
European_Hidden_Gem_Stocks on MINT Société anonyme ·

Mint SA: A French Micro-Cap Energy Retailer Worth Watching

Fair Value:€1153.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.916.3% undervalued
89 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28029.6% undervalued
200 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6510.3% undervalued
73 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0